Stocks · News reference
'FDA’s Acting Drug, Vaccine Regulators Tapped for Permanent Roles'- Bloomberg
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Moderna, Vaxcyte and Novavax Are Trending After-Hours as Suspected Pneumonic Plague In Russia Stirs Anxiety
Vaccine stocks are trending on Tuesday. Shares of Moderna Inc. (NASDAQ:MRNA), Vaxcyte Inc. (NASDAQ:PCVX) and Novavax Inc. (NASDAQ:NVAX) are moving in the after-hours session on Monday. Moderna rose 0.17% to
JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $165
JP Morgan analyst Chris Schott maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $150 to $165.
Most Undervalued Chip Stocks In October 2026: Four Are Cheaper Than The S&P 500
Undervalued chip stocks in October 2026: Micron, NXP, Qualcomm and Nvidia trade below the S&P 500's forward P/E of 20.3.
'France and Germany say diesel promise to Trump won’t require new stock release' - Politico Exclusive
https://www.politico.eu/article/france-and-germany-say-diesel-promise-to-trump-wont-require-new-stock-release/
S&P 500 Faces a 'Stealth Correction' as Earnings Boom Collides With Rising Yields, Warns Fidelity’s Timmer: Market Is ‘In a Vice'
Fidelity's Jurrien Timmer warns the S&P 500 is in a 'stealth correction' as 'opposing forces' of rising yields and an earnings boom collide.